Your browser doesn't support javascript.
loading
Impact of Therapy Management on Axitinib-Related Adverse Events in Patients With Advanced Renal Cell Carcinoma Receiving First-Line Axitinib + Checkpoint Inhibitor.
Zakharia, Yousef; Huynh, Lynn; Du, Shawn; Chang, Rose; Pi, Selina; Sundaresan, Sanjana; Duh, Mei S; Zanotti, Giovanni; Thomaidou, Despina.
Afiliación
  • Zakharia Y; University of Iowa, Holden Comprehensive Cancer Center, Iowa City, IA. Electronic address: yousef-zakharia@uiowa.edu.
  • Huynh L; Analysis Group, Inc, Boston, MA. Electronic address: Lynn.Huynh@analysisgroup.com.
  • Du S; Analysis Group, Inc, New York, NY.
  • Chang R; Analysis Group, Inc, Boston, MA.
  • Pi S; Analysis Group, Inc, New York, NY.
  • Sundaresan S; Analysis Group, Inc, Boston, MA.
  • Duh MS; Analysis Group, Inc, Boston, MA.
  • Zanotti G; Pfizer, Inc, New York, NY.
  • Thomaidou D; Pfizer Hellas, Athens, Greece.
Clin Genitourin Cancer ; 21(5): e343-e351, 2023 10.
Article en En | MEDLINE | ID: mdl-37087399

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Genitourin Cancer Asunto de la revista: NEOPLASIAS / UROLOGIA Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Genitourin Cancer Asunto de la revista: NEOPLASIAS / UROLOGIA Año: 2023 Tipo del documento: Article